Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer-Reference-Cited by-同舟云学术

Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer

Published:2019-12-04 Issue:3 Volume:47 Page:652-664
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Ferraro Daniela A.,Garcia Schüler Helena I.,Muehlematter Urs J.,Eberli Daniel,Müller Julian,Müller Alexander,Gablinger Roger,Kranzbühler Helmut,Omlin Aurelius,Kaufmann Philipp A.,Hermanns Thomas,Burger Irene A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04568-1.pdf

Reference59 articles.

1. Abdel-Rahman O. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; a time to sub-classify stage IV? PLoS One. 2017;12:e0188450. https://doi.org/10.1371/journal.pone.0188450.

2. American Joint Committee on C, Amin MB. AJCC cancer staging manual. New York: Springer; 2017.

3. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71:618–29. https://doi.org/10.1016/j.eururo.2016.08.003.

4. de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol. 2016;70:233–45. https://doi.org/10.1016/j.eururo.2015.07.029.

5. Hovels AM, Heesakkers RA, Adang EM, Jager GJ, Strum S, Hoogeveen YL, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63:387–95. https://doi.org/10.1016/j.crad.2007.05.022.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy;Diagnostics;2024-09-05

2. Prostate-specific Membrane Antigen;PET Clinics;2024-07

3. Dual-time-point dynamic 68Ga-PSMA-11 PET/CT for parametric imaging generation in prostate cancer;Annals of Nuclear Medicine;2024-05-18

4. Fluorine-18 prostate-specific membrane antigen-1007-avid indeterminate bone lesions in prostate cancer: clinical and PET/CT features to predict outcomes and prognosis;Clinical Radiology;2024-05

5. Impact of ⁶⁸Ga-PSMA PET/CT on Survival and Management in Prostate Cancer;Current Medical Imaging Formerly Current Medical Imaging Reviews;2024-04-26